State of Play of Non-tuberculous Mycobacteria in Alsace
Mycoba
1 other identifier
observational
100
1 country
1
Brief Summary
Non-tuberculous mycobacteriosis (NTM) are infectious diseases caused by mycobacteria that are not part of the Tuberculosis complex. More than 190 species have been identified to date. As an environmental reservoir, it most often affects the lungs, skin and soft tissues, lymph nodes, but it can affect all organs. Varying in virulence depending on the species, most infections do not cause illness. There is currently no coordinated care pathway for this pathology in Alsace. The means necessary to set up such a structure requires knowing the importance of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2022
CompletedFirst Submitted
Initial submission to the registry
December 14, 2023
CompletedFirst Posted
Study publicly available on registry
December 29, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2024
CompletedDecember 29, 2023
December 1, 2023
1.5 years
December 14, 2023
December 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective description of non-tuberculous mycobacteria in Alsace
Through study completion, an average of 6 months
Eligibility Criteria
Adult subject (≥ 18 years old) in whom a biological sample is culture positive for a non-tuberculous mycobacterium
You may qualify if:
- Adult subject (≥ 18 years old)
- in whom a biological sample is culture positive for a non-tuberculous mycobacterium
- born in France and domiciled in Alsace (i.e. whose home postal code begins with 67 or 68)
- not opposing the reuse of its data for scientific research purposes
You may not qualify if:
- Subject having expressed opposition to participating in the study
- not domiciled in Alsace
- Born abroad
- Isolation of a mycobacterium from the Tuberculosis complex and Mycobacterium gordonae
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Pneumologie - CHU de Strasbourg - France
Strasbourg, 67091, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2023
First Posted
December 29, 2023
Study Start
December 5, 2022
Primary Completion
June 1, 2024
Study Completion
June 5, 2024
Last Updated
December 29, 2023
Record last verified: 2023-12